Literature DB >> 20369037

The relationship between the polymorphism of SG13S114 A/T in ALOX5AP gene and the vulnerability of carotid atherosclerosis in Chinese Han population.

Xiaoping Jin1, Yinglei He, Min Zhu, Xianfang Lin, Qiuyue Chen, Zhao Han, Xiaoya Huang, Feng Wang.   

Abstract

The purpose of this study was to determine the relationship between the polymorphism of SG13S114 A/T in ALOX5AP gene and the vulnerability of carotid atherosclerosis in Chinese Han population. Polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) of SG13S114 A/T in ALOX5AP gene was performed for 284 patients with atherothrombotic cerebral infarction, of which 152 cases were diagnosed with stable plaque and the other 132 cases had vulnerable plaques. We found that the frequency of SG13S114 AA genotype and A allele of ALOX5AP gene in the cases with vulnerable plaques was significantly higher than those in the cases with stable plaques. These results suggested that high expression of SG13S114 AA genotype was related to the vulnerability of carotid atherosclerosis. SG13S114 A allele may be a risk factor of vulnerable plaques.

Entities:  

Keywords:  5-lipoxygenase activating protein; atherosclerosis; gene polymorphism; polymerase chain reaction

Year:  2010        PMID: 20369037      PMCID: PMC2848303     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

1.  From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation.

Authors:  Raffaele De Caterina; Antonella Zampolli
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

2.  A new subtype classification of ischemic stroke based on treatment and etiologic mechanism.

Authors:  Sang Won Han; Seo Hyun Kim; Jong Yun Lee; Chong Kyu Chu; Jae Hoon Yang; Ha Young Shin; Hyo Suk Nam; Byung In Lee; Ji Hoe Heo
Journal:  Eur Neurol       Date:  2006-12-15       Impact factor: 1.710

3.  Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort.

Authors:  Wei-Li Zhang; Xiao-Min Yang; Jia Shi; Kai Sun; Ru-Tai Hui
Journal:  Yi Chuan Xue Bao       Date:  2006-08

4.  Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis.

Authors:  Mark Fisher; Annlia Paganini-Hill; Aldana Martin; Michele Cosgrove; James F Toole; Henry J M Barnett; John Norris
Journal:  Stroke       Date:  2005-01-13       Impact factor: 7.914

5.  Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study.

Authors:  E B Mathiesen; K H Bønaa; O Joakimsen
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

6.  Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke.

Authors:  Luigi Giusto Spagnoli; Alessandro Mauriello; Giuseppe Sangiorgi; Stefano Fratoni; Elena Bonanno; Robert S Schwartz; David G Piepgras; Raimondo Pistolese; Arnaldo Ippoliti; David R Holmes
Journal:  JAMA       Date:  2004-10-20       Impact factor: 56.272

7.  Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.

Authors:  A Helgadottir; S Gretarsdottir; D St Clair; A Manolescu; J Cheung; G Thorleifsson; A Pasdar; S F A Grant; L J Whalley; H Hakonarson; U Thorsteinsdottir; A Kong; J Gulcher; K Stefansson; M J MacLeod
Journal:  Am J Hum Genet       Date:  2005-01-07       Impact factor: 11.025

8.  Identification and isolation of a membrane protein necessary for leukotriene production.

Authors:  D K Miller; J W Gillard; P J Vickers; S Sadowski; C Léveillé; J A Mancini; P Charleson; R A Dixon; A W Ford-Hutchinson; R Fortin
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

9.  Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.

Authors:  R A Dixon; R E Diehl; E Opas; E Rands; P J Vickers; J F Evans; J W Gillard; D K Miller
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

Review 10.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

View more
  2 in total

1.  Association of oxysterol binding protein-related protein 9 polymorphism with cerebral infarction in Hunan Han population.

Authors:  Lingjuan Li; Geyue Qu; Mingyue Wang; Qing Huang; Yunhai Liu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

2.  The involvement of 5-lipoxygenase activating protein in anxiety-like behavior.

Authors:  Yash B Joshi; Domenico Praticò
Journal:  J Psychiatr Res       Date:  2013-01-26       Impact factor: 4.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.